poisar

Stock

enVVeno Medical Corporation NVNO

$10.71-1.34%

Overview

NVNO market data

Price History

NVNO price chart

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$1.29
Diluted earnings per share over the trailing twelve months.
Beta
1.24
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-5,483.3%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$8.67 – $178.15
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $7M · P/B 0.24 · P/S 38.88.

Company News

7 captured
enVVeno Announces Publication Of Peer-Reviewed Health Economics Study Supporting Venous Valve Therapy; Findings May Support Future Coverage And Reimbursement DecisionsBenzinga · Aug 4, 2026, 12:49 PM
enVVeno Medical Says Peer-Reviewed Study Projects More Than $32K In Healthcare Savings Per Patient Over Five Years From Venous Valve Replacement TherapyBenzinga · Aug 4, 2026, 12:48 PM
enVVeno Medical Q2 EPS $(5.37) Up From $(11.55) YoYBenzinga · Jul 31, 2026, 12:58 PM
enVVeno Medical Says It Received FDA IDE Approval For TAVVE Pivotal Study Of enVVe Replacement Venous Valve, Enrollment Of Approximately 230 Patients Expected To Begin In H2 2026Benzinga · Jul 31, 2026, 12:35 PM
enVVeno Medical Highlights Recently-Announced U.S. Patent For enVVe System For Non-Surgical Replacement Venous ValvesBenzinga · Jul 15, 2026, 12:34 PM
8-K filing — enVVeno Medical Corp (NVNO)SEC EDGAR · Jul 14, 2026, 8:55 PM
EnVVeno Medical Issued U.S. Patent For Its Intellectual Property Portfolio Supporting Its enVVe Transcatheter Replacement Venous Valve System To Treat Venous DiseaseBenzinga · Jul 7, 2026, 12:35 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock